Communiqués ANI Pharmaceuticals, Inc.

Actions

ANIP

US00182C1036

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 07/06/2024			Varia. 5j.	Varia. 1 janv.
66,74 ^USD	-3,02 %		+2,84 %	+21,04 %

06/06	Un initié d'Ani Pharmaceuticals a vendu des actions pour une valeur de 317 900 $, selon un récent dépôt auprès de la SEC	MT
05/06	Un initié d'ANI Pharmaceuticals a vendu des actions pour une valeur de 1 288 200 $, selon un récent dépôt auprès de la SEC	MT

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

ANI Pharmaceuticals to Present at the 2024 Jefferies Global Healthcare Conference	29/05	AQ
Purcell & Lefkowitz LLP Announces Shareholder Investigation of ANI Pharmaceuticals, Inc. (NASDAQ: ANIP)	20/05	PR
ANI Pharmaceuticals Announces the Launch of Kionex® Suspension	20/05	AQ
ANI PHARMACEUTICALS REPORTS RECORD FIRST QUARTER 2024 FINANCIAL RESULTS AND REITERATES 2024 GUIDANCE	13/05	AQ
ANI: Q1 Earnings Snapshot	10/05	AQ
ANI Pharmaceuticals Reports Record First Quarter 2024 Financial Results and Reiterates 2024 Guidance	10/05	AQ
ANI Pharmaceuticals to Participate at Two Upcoming Healthcare Conferences	01/05	AQ
ANI Pharmaceuticals to Discuss First Quarter 2024 Financial Results on May 10, 2024, at 8:30 a.m. ET	18/04	AQ
ANI Pharmaceuticals : Corporate Presentation - April 2024	17/04	PU
ANI Pharmaceuticals Announces the Launch of Baclofen Oral Suspension	09/04	AQ
ANI Pharmaceuticals Recognizes Sarcoidosis Awareness Month and Patients Living with Sarcoidosis	04/04	AQ
ANI Pharmaceuticals to Participate at the Piper Sandler Spring Biopharma Symposium	03/04	AQ
ANI Pharmaceuticals Announces the Launch of Levofloxacin Oral Solution, USP	27/03	AQ
ANI Pharmaceuticals : Corporate Presentation - March 2024	12/03	PU
ANI: Q4 Earnings Snapshot	29/02	AQ
ANI Pharmaceuticals Reports Fourth Quarter and Record Full-Year 2023 Financial Results and Provides 2024 Guidance	29/02	AQ
ANI Pharmaceuticals to Present at the Leerink Partners Global Biopharma Conference	20/02	AQ
ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024, at 8:30 a.m. ET	07/02	AQ
ANI Pharmaceuticals to Participate at the Guggenheim Healthcare Talks \| 6th Annual Biotechnology Conference	29/01	AQ
ANI Pharmaceuticals Announces the Launch of Pentoxifylline Extended-Release Tablets, USP	23/01	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués ANI Pharmaceuticals, Inc.

Actions

ANIP

US00182C1036

Communiqués

Filtres